# To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty

> **NCT07121101** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Beijing Tide Pharmaceutical Co., Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Postoperative Analgesia After Unilateral Hip Arthroplasty

## Interventions

- **DRUG:** TRD205 tablets
- **DRUG:** TRD205 tablets
- **DRUG:** TRD205 tablets
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07121101
- **Lead sponsor:** Beijing Tide Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-26
- **Primary completion:** 2025-11-20
- **Final completion:** 2025-12-27
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07121101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07121101, "To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07121101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*